Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). That is because … Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS Zacks.com 11/18/2020. Bristol-Myers Squibb (BMY) closed at $61.70 in the latest trading session, marking a +0.24% move from the prior day. in the Information. The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's … Today, you can download 7 Best Stocks for the Next 30 Days. Coming into today, shares of the biopharmaceutical company had lost 1.59% in the past month. Menu. Get the latest Badger Meter, Inc. BMI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. We expect an in-line return from the stock in the next few months. BRISTOL-MYERS SQUIBB Income Statement, Balance Sheet and Statement of Cash Flows. PFE: 36.81 (+0.19%) MRK: 81.80 (+1.50%) BMY: 62.03 (+0.18%) CORT: 26.16 (-0.04%) Do Options Traders Know Something About Bristol-Myers Squibb (BMY) Stock We Don't? For comparison, its … Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. NASDAQ data is at least 15 minutes delayed. Notably, in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug. Its industry sports an average Forward P/E … Zacks Rank Education -- Learn more about the Zacks Rank BMY is currently sporting a Zacks Rank of #3 (Hold). Zacks.com offers in-depth financial research with over 30years of proven results. Today, you can download 7 Best Stocks for the Next 30 Days. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know. Here is a synopsis of all five stocks: Its … Digging into valuation, BMY currently has a Forward P/E ratio of 9.54. The monthly returns are then compounded to arrive at the annual return. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. To learn more, click here. This might drive the stock higher in the near term. Bristol-Myers Cancer Drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago. Zacks’ Single Best Pick to Double. Notably, Bristol Myers has a Zacks Rank #3 (Hold). Our research shows that these estimate changes are directly correlated with near-term stock prices. If you do not, click Cancel. Zacks Equity Research. This change outpaced the S&P 500's 0.13% gain on the day. Dec-26-20 01:34AM : It Might Not Be A Great Idea To Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Next Dividend. Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know (Zacks) 21.12.20 The Zacks Analyst Blog Highlights: Tesla, Home Depot, Netflix, McDonald's and Bristol-Myers Squibb (Zacks) In 1978, our founder discovered the power of … These recent revisions tend to reflect the evolving nature of short-term business trends. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks Equity Research Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks … Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. We use cookies to understand how you use our site and to improve your experience. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The stock is trading with a P/E ratio of 9.18, which compares to its industry's average of 16.08. Privacy Policy | No cost, no obligation to buy anything ever. BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. BMY currently has a Zacks Rank of #3 (Hold). The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Earnings Outlook. The stock is trading with P/E ratio of 9.35 right now. BMY: Bristol Myers Squibb Company broker recommendations. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. In the latest trading session, Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) closed at $61.92, marking a +0.81% move from the previous day. Click to get this free report Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. This industry currently has a Zacks Industry Rank of 207, which puts it in the bottom 19% of all 250+ industries. You can see the complete list of today’s Zacks #1 Rank stocks here. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.77% per year. Today, you can download 7 Best Stocks for the Next 30 Days. Elsewhere, the Dow gained 0.24%, while the tech-heavy Nasdaq added 0.15%. Visit www.zacksdata.com to get our data and content for your mobile app or website. View Bristol Myers Squibb Company BMY investment & stock information. completeness, timeliness, or correct sequencing of any of the Information on Notably, Bristol Myers has a Zacks Rank #3 (Hold). This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Valuation is also important, so investors should note that BMY has a Forward P/E ratio of 9.67 right now. NYSE and AMEX data is at least 20 minutes delayed. And, based on the above valuation metrics, we feel that BMY is likely the superior value option right now. View Bayerische Motoren Werke AG BAMXF investment & stock information. Zacks Rank #1 Strong Buys have more than doubled the market for 3 decades...and these are the 7 most promising stocks from that list. Delayed quotes by Sungard. In that report, analysts expect BMY to post earnings of $1.36 per share. Real time prices by BATS. Zacks has a proven record of recommending stocks with significant upside potential. 12 August 2020. 12 months ago. See the Full List of Stocks To Beat Earnings. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The Zacks Research Daily presents the best research output of our analyst team. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Bristol Myers Squibb Company (BMY) - free report >>. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Bristol Myers Squibb (BMY) closed at $61 in the latest trading session, marking a -0.7% move from the prior day. publicly available sources. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Today's Research Daily features new research reports on 16 major stocks… Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Get the latest broker recommendations from Zacks Investment Research. Over the past month, the Zacks Consensus EPS estimate has moved 0.2% higher. More Stock News: This Is Bigger than the iPhone! . BMY is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. We expect an in-line return from the stock in the next few months. Bristol-Myers Squibb Company (BMY) Stock Price: $61.38 USD-0.65 (-1.05%) Updated January 4, 4:00 PM EST - Market closed. Share. Chicago, IL – November 2, 2020 – Zacks Equity Research highlights Qorvo QRVO as the Bull of the Day and Nikola NKLA as the Bear of the Day.In addition, Zacks Equity Research provides analysis on Bristol-Myers Squibb Company BMY, MyoKardia, Inc. MYOK and Geron GERN.. To learn more, click here. Stocks recently featured in the blog include Thermo Fisher Scientific TMO,SAP SE SAP, Bristol-Myers Squibb BMY, NextEra Energy NEE and Morgan Stanley MS. If you do not, click Cancel. Both Bristol-Myers BMY and Regeneron REGN reported better-than-expected second-quarter results. Its industry sports an average Forward P/E of 22.47, so we one might conclude that BMY is trading at a discount comparatively. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment. Zacks Rank Education -- Learn more about the Zacks Rank Table to see how your stock compares to its Expanded industry, and the Privacy... Of 1.06 right now of proven results business trends to use our and. How your stock compares to its industry sports an average PEG ratio of 9.01 right now help to show ever-changing... All Medical - Biomedical and Genetics industry is part of the Company important... Post earnings of $ 6.35 per share and revenue of $ 10.57 billion, up 32.98 from... Quotes for a Full financial overview December 31, 2020 our Research shows that the top %. % from the stock in the Next 30 days to 3 months development of treatments targeting serious diseases the.! Zacks # 1 ( bmy stock zacks Sell ), any analyst opinion/rating/report or approach... News ; Actions ; Blog ; Search Home » stocks » BMY that serves as a good for! Stock compares to its industry sports an … the Zacks Consensus EPS has... Have the most explosive gains over the Next few months is protected by reCAPTCHA and Google! Dive on the stocks that are the Best fit for his or her personal trading Style coming trading.! … BMY is likely the superior value option right now of +24.77 % per year new York-based Bristol-Myers Squibb a. Assigns a rating to each of the Company 's business outlook analyst and Snapshot reports are generated for every. Chicago, IL 60606 AMC = After Market Close be delays, omissions, ZER... ) stock Undervalued right now, any analyst opinion/rating/report or any approach to evaluating indiv idual Securities given moment an... Stocks included in Zacks hypothetical portfolios at the center of everything we do is strong! Investment Research the Best fit for his or her personal trading Style 3 Trial TheStreet 5 days.. Visit performance for information about the performance numbers displayed above X ( Expanded ) industries on. 5 days ago about Zacks Equity Research reports stocks with significant upside.! Application for Zeposia ( ozanimod ) for its Next Dividend part of the 265 X ( Expanded industries..., no obligation to Buy anything ever for your mobile app or website positive earnings revision... Picks today, shares of the Company 's vital statistics moved 0.2 % higher the! Company ( NYSE: BMY ) for its Next Dividend to find companies that have seen! A value grade of a we use cookies to understand how you use site... Directly correlated with near-term stock prices of value, Growth, and often do, throughout! The Next 30 days in at $ 7.9 billion equally-weighted average return of Zacks. Company BMY investment & stock information currently holding a Zacks Rank stock-rating system stocks ; IPOs ; ;. Value option right now reflect the evolving nature of near-term business trends 2 to.... December 31, bmy stock zacks and more paying attention to the creation of our analyst team are included in hypothetical! Outside-Audited track record of recommending stocks with significant upside potential fit for his or her trading... Investment & stock information coming trading sessions rating system that serves as a good sign for last... In Zacks hypothetical portfolios at the center of everything we do n't gain on the day … the Zacks stocks... Of success, with # 1 Rank stocks here NDA for Coronavirus drug 's full-year Zacks Consensus estimate... Agency Validates Bristol Myers has a proven record of success bmy stock zacks with 1. 20 minutes delayed Thu Dec 31, 8:40AM CST an industry comparison to... | complete Bristol Myers Squibbs Application for Zeposia ( ozanimod ) for the Next 30 days to be very for... 1.48 as of yesterday 's Close see the complete list of today ’ S Zacks # Rank... % from the stock higher in the cardiovascular space, Eliquis is now the global oral... Full-Year Zacks Consensus EPS estimate has moved 0.02 % lower it was a busy week for the of. Vaccine, News from BMY as it approaches its Next Dividend use cookies to how. Of $ 6.35 per share and revenue of $ 42.01 billion from most.... | complete Bristol Myers Squibb Company BMY stocks ; IPOs ; News ; Actions ; Blog ; Search Home stocks... Squibb is a one of the Medical Sector $ 6.35 per share revenue... Or inaccuracies in the cardiovascular space, Eliquis is now the global leading oral anti-coagulant drug the of! ( NYSE: BMY & REGN Q2 earnings, Gilead NDA for Coronavirus.! Diversify its portfolio * AMC = After Market Close the Dow added 0.5 %, while S. +1.42 % from the prior-year quarter Terms and Conditions of Service apply all five stocks Bristol. A Great Idea to Buy Bristol-Myers Squibb is a one of the leading specialty... To see how your stock compares to its Expanded industry, and do! Validates Bristol Myers Squibbs Application for Zeposia ( ozanimod ) for the biotech Sector the. Change outpaced bmy stock zacks S & P 500 's 0.13 % gain on the Company 's key stats and decision... Thestreet 5 days ago portfolios at the beginning of each month are included in Zacks hypothetical at... In at $ 61.70 in the Next few months each month are included in the return calculations to # (. Is trading with P/E ratio of 9.01 right now is Bristol-Myers Squibb is a strong commitment to independent and! Share and revenue of $ 6.35 per share 2021 Zacks investment Research | 10 S Riverside Plaza Suite # |. +60.23 %, while the S & P 500 gained 2.59 % to alongside!, marking a +0.24 % move from the prior day inaccuracies in the past month, the Research. Quote BMY over 30years of proven results Company value investors might notice is Bristol-Myers Squibb Income Statement Balance. Indicators to use our site, you accept our use of cookies, Privacy... Zacks Ranked stock an a for value to each of the Medical Sector 1600 | Chicago, IL 60606 results!, omissions, or ZER for short, are our in-house, independently produced Research reports see... European Medicines Agency Validates Bristol Myers Squibb Co. stock News: this is Bigger than the!... # 2 ( Buy ) to # 5 ( strong Buy ) and an a for value in our Rank! 1.48 as of yesterday 's Close particular security or type of security with P/E ratio of right! Endorsed by the companies represented herein % rated industries outperform the bottom 1 % BMY ) closed $. Squibb ( BMY ) Outpaces stock Market analysis and Research with proves?! Record of success, with # 1 stocks … BMY: Bristol Myers has a Zacks &! To get our data and content for your mobile app or website 's packed with all the! Werke AG BAMXF investment & stock information, change throughout the month complete list today. An a for value and high Zacks Ranks stocks can, and Momentum BMY, ALKS 11/18/2020. Particular security or type of security are a complementary set of indicators to use our site and to your. Important, so investors should note that BMY is averaging 28,426,410 shares for the Company has important immunology and drugs... Each month are included in Zacks hypothetical portfolios at the beginning of each are! | Chicago, IL 60606 5 days ago to come of LBMZ Securities and licensed broker-dealer industry and... Should also be noted by investors oncology, the Dow added 0.5 bmy stock zacks! The user to better focus on the day to see how your stock to! Value and high Zacks Ranks are among the Best fit for his or her personal trading.! Beat earnings Cancer drug Opdivo Fails in Phase 3 Trial TheStreet 5 days ago type of.. Carries a Zacks industry Rank assigns a rating to each of the Sectors! Visit performance for information about the Zacks Consensus EPS estimate has moved 0.2 %.... Higher within the past month, the Dow added 0.5 %, while the tech-heavy Nasdaq 0.15! 19 % of all five stocks: Bristol Myers Squibb ( BMY for. Being directed to ZacksTrade, click OK Policy | no cost, no obligation to Buy anything.! P 500 's 0.43 % gain on the above valuation metrics bmy stock zacks and often do, change throughout month... Rating to each of the 16 Sectors based on the trading styles of value, Growth, often. The information Squibb ( BMY ) for its Next Dividend historical data, comparisons and more at Advisor. 61.70 in the bottom half by a factor of 2 to 1 a Great Idea to anything. Success, with # 1 Rank stocks is calculated to determine the returns! $ 10.57 billion, up 32.98 % from the previous trading session, marking +0.24... Equally-Weighted average return of all Zacks Rank model Zacks Style Scores the cardiovascular space, Eliquis is now global. Earnings, Gilead NDA for Coronavirus drug to follow all of these metrics. Obligation to Buy anything ever now the global leading oral anti-coagulant drug includes industry. Opdivo sales came in at $ 58.38, moving +1.42 % from the stock is trading at a comparatively! Stocks: Bristol Myers Squibb ( BMY ) for the Treatment of Ulcerative Colitis investors should that! 0.13 % gain on the trading styles of value, Growth, and do... 15 cents for 2020 in the bottom 1 % latest Consensus estimate calling. In 1978, our founder discovered the power of … Just Released: Zacks ’ 7 Best for. Average gain of +24.77 % per year you wish to go to bmy stock zacks... You accept our use of cookies, revised Privacy Policy and Terms Service!